デフォルト表紙
市場調査レポート
商品コード
1713596

光沢苔癬治療の世界市場レポート 2025年

Lichen Nitidus Treatment Global Market Report 2025


出版日
ページ情報
英文 175 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.90円
光沢苔癬治療の世界市場レポート 2025年
出版日: 2025年04月23日
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

光沢苔癬治療市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.5%で27億1,000万米ドルに成長します。予測期間の成長は、製薬企業による希少疾患への注目の高まり、先進的な免疫調節剤による標的治療の選択肢の創出、窒化苔癬などの希少皮膚疾患の診断率の向上、自己免疫疾患の世界の罹患率の増加などに起因すると考えられます。予測期間における主な開発動向としては、個別化アプローチ、標的特異的免疫応答、遠隔医療プラットフォームと遠隔診断ツール、人工知能を活用した診断と治療、希少疾病用医薬品開発へのインセンティブなどが挙げられます。

化学物質への曝露の増加は、今後数年間の光沢苔癬治療市場の成長を促進すると予想されます。化学物質曝露とは、有害物質との接触を意味し、吸入、摂取、皮膚接触によって起こり、呼吸器障害や皮膚障害などの健康問題を引き起こす可能性があります。一般的には、環境、職場、家庭内に存在する有害物質との直接接触によって引き起こされ、吸入、摂取、皮膚から吸収され、さまざまな健康リスクをもたらします。化学物質への暴露は、炎症反応を引き起こしたり、皮膚を刺激したりすることによって窒化苔癬の一因となる可能性があり、免疫系を混乱させ、症状の開発に関与する可能性があります。例えば、2023年11月にComing Clean Inc.が報告したところによると、2021年1月から2023年10月までに米国では825件以上の危険化学物質事故が発生し、150件以上が化学物質曝露による負傷、入院、急性症状を引き起こしました。その結果、化学物質曝露の大幅な増加が、窒化苔癬治療の需要を牽引しています。

皮膚感染症の有病率の増加も、光沢苔癬治療市場を押し上げると予想されています。皮膚感染症は、細菌、真菌、ウイルスなどの微生物が皮膚に侵入することで発生し、さまざまな症状や不快感を引き起こします。これらの感染症は、細菌、ウイルス、真菌、寄生虫を含む複数の病原体によって引き起こされる可能性があります。皮膚感染症が増加するにつれて、効果的な治療法、抗生物質、硝酸苔癬を管理するための新しい治療法に対する需要も増加し、患者が最善の治療を受けられるようになっています。例えば、英国医療安全保障局(UKHSA)は2022年9月、皮膚・軟部組織感染症に関連するメチシリン耐性黄色ブドウ球菌(MRSA)症例が2021年と比較して2022年には33.7%増加したと報告しました。さらに、2020年4月から2021年3月までの会計年度中にMRSA症例は25.7%増加しました。したがって、皮膚感染症の有病率の増加は、光沢苔癬治療に対する需要をさらに煽ると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場:金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の光沢苔癬治療PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の光沢苔癬治療市場:成長率分析
  • 世界の光沢苔癬治療市場の実績:規模と成長, 2019-2024
  • 世界の光沢苔癬治療市場の予測:規模と成長, 2024-2029, 2034F
  • 世界の光沢苔癬治療総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の光沢苔癬治療市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • オーラル
  • トピック
  • 世界の光沢苔癬治療市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • コルチコステロイド
  • レチノイド
  • 抗ヒスタミン薬
  • 光線療法
  • 世界の光沢苔癬治療市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 病院
  • 皮膚科クリニック
  • その他のエンドユーザー
  • 世界の光沢苔癬治療市場、口腔のサブセグメンテーション、カテゴリー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経口薬(ステロイド)
  • 経口薬(免疫抑制剤)
  • 経口抗ヒスタミン薬
  • 経口レチノイド
  • 世界の光沢苔癬治療市場、トピックのサブセグメンテーション、カテゴリ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 局所ステロイド
  • 局所カルシニューリン阻害剤
  • 局所レチノイド
  • 局所抗ヒスタミン薬
  • 局所光線療法

第7章 地域別・国別分析

  • 世界の光沢苔癬治療市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の光沢苔癬治療市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 光沢苔癬治療市場:競合情勢
  • 光沢苔癬治療市場:企業プロファイル
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Sanofi S.A.
  • Bristol-Myers Squibb Co.
  • AstraZeneca Plc
  • GlaxoSmithKline Plc
  • Roche Holding AG
  • Takeda Pharmaceutical Company Limited
  • Amgen Inc.
  • Eli Lilly and Company
  • Regeneron Pharmaceuticals Inc.
  • Biogen Inc.
  • UCB Pharma Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Incyte Corporation
  • Kyowa Kirin Co. Ltd.
  • Mallinckrodt Pharmaceuticals Plc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 光沢苔癬治療市場2029:新たな機会を提供する国
  • 光沢苔癬治療市場2029:新たな機会を提供するセグメント
  • 光沢苔癬治療市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r33498

Lichen nitidus treatment involves medical approaches designed to manage and alleviate the symptoms of this rare skin condition, which is characterized by small, shiny, flesh-colored bumps. The goal of treatment is to reduce discomfort and enhance skin appearance, particularly in cases that are persistent or symptomatic.

The main types of lichen nitidus treatments are oral and topical. Oral treatments are taken by mouth and work systemically to address the condition. These include corticosteroids, retinoids, antihistamines, and phototherapy. These treatments are used by various end users such as hospitals, dermatology clinics, and other medical facilities.

The lichen nitidus treatment market research report is one of a series of new reports from The Business Research Company that provides lichen nitidus treatment market statistics, including lichen nitidus treatment industry global market size, regional shares, competitors with a lichen nitidus treatment market share, detailed lichen nitidus treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the lichen nitidus treatment industry. This lichen nitidus treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lichen nitidus treatment market size has grown strongly in recent years. It will grow from $1.88 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to increased understanding of rare skin diseases, use of corticosteroids and other topical treatments as off-label options, general rise in autoimmune disease awareness and diagnostics.

The lichen nitidus treatment market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to growing attention to orphan diseases by pharmaceutical companies, advanced immunomodulators may create targeted treatment options, increase the diagnosis rate of rare skin diseases such as lichen nitidus, increasing global incidence of autoimmune disorders. Major trends in the forecast period include focus on personalized approaches, target specific immune responses, telemedicine platforms and remote diagnostic tools, artificial intelligence-driven diagnostics and treatment, incentives for orphan drug development.

The increasing exposure to chemicals is expected to drive the growth of the lichen nitidus treatment market in the coming years. Chemical exposure refers to contact with harmful substances, which can occur through inhalation, ingestion, or skin contact, potentially leading to health issues such as respiratory problems or skin disorders. It is typically caused by direct contact with hazardous substances found in the environment, workplaces, or households, which can be absorbed through inhalation, ingestion, or the skin, posing various health risks. Chemical exposure may contribute to lichen nitidus by triggering an inflammatory response or irritating the skin, potentially disrupting the immune system and playing a role in developing the condition. For example, in November 2023, Coming Clean Inc. reported that from January 2021 to October 2023, the US saw over 825 hazardous chemical incidents, with more than 150 cases resulting in injury, hospitalization, or acute symptoms due to chemical exposure. As a result, the significant rise in chemical exposure is driving the demand for lichen nitidus treatments.

The increasing prevalence of skin infections is also expected to boost the lichen nitidus treatment market. Skin infections occur when microorganisms such as bacteria, fungi, or viruses invade the skin, causing various symptoms and discomfort. These infections can be caused by several pathogens, including bacteria, viruses, fungi, and parasites. As skin infections rise, so does the demand for effective therapeutic solutions, antibiotics, and new treatments to manage lichen nitidus, ensuring patients receive the best possible care. For example, the UK Health Security Agency (UKHSA) reported in September 2022 that Methicillin-resistant Staphylococcus aureus (MRSA) cases linked to skin and soft tissue infections increased to 33.7% in 2022 compared to 2021. Additionally, MRSA cases rose by 25.7% during the financial year from April 2020 to March 2021. Therefore, the growing prevalence of skin infections is expected to further fuel the demand for lichen nitidus treatments.

Key companies in the lichen nitidus treatment market are focusing on developing innovative topical products to provide targeted relief, reduce inflammation, and enhance skin barrier function. These advanced formulations are designed to offer more effective and convenient treatment options, improving patient comfort and addressing the unique needs of those affected by lichen nitidus. For instance, in August 2023, Glenmark Pharmaceuticals, an Indian pharmaceutical company, received approval for Tacrolimus Ointment, 0.03% under sANDA. This ointment, an effective topical treatment for lichen nitidus, leverages its immunosuppressive properties to alleviate symptoms and improve skin appearance. It is a generic version of Protopic Ointment, 0.03%, originally manufactured by Leo Pharma AS, and is intended for treating moderate to severe atopic dermatitis.

Major companies operating in the lichen nitidus treatment market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Co., AstraZeneca Plc, GlaxoSmithKline Plc, Roche Holding AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Eli Lilly and Company, Regeneron Pharmaceuticals Inc., Biogen Inc., UCB Pharma Ltd., Sun Pharmaceutical Industries Ltd., Incyte Corporation, Kyowa Kirin Co. Ltd., Mallinckrodt Pharmaceuticals Plc, Glenmark Pharmaceuticals Ltd., Almirall S.A., Galderma Laboratories Lp, Leo Pharma A/S, Allergan Plc, Valeant Pharmaceuticals Australasia Pty Ltd

North America was the largest region in the lichen nitidus treatment market in 2024. The regions covered in the lichen nitidus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lichen nitidus treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lichen nitidus treatment market consists of sales of topical corticosteroids, ultraviolet light therapy, and systemic corticosteroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lichen Nitidus Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lichen nitidus treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lichen nitidus treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The lichen nitidus treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Oral; Topical
  • 2) By Treatment: Corticosteroids; Retinoid; Antihistamines; Phototherapy
  • 3) By End User: Hospitals; Dermatology Clinics; Other End Users
  • Subsegments:
  • 1) By Oral: Oral Medications (Steroids); Oral Medications (Immunosuppressants); Oral Antihistamines; Oral Retinoids
  • 2) By Topical: Topical Steroids; Topical Calcineurin Inhibitors; Topical Retinoids; Topical Antihistamines; Topical Phototherapy
  • Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; Merck & Co Inc.; AbbVie Inc.; Novartis AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Lichen Nitidus Treatment Market Characteristics

3. Lichen Nitidus Treatment Market Trends And Strategies

4. Lichen Nitidus Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Lichen Nitidus Treatment Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Lichen Nitidus Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Lichen Nitidus Treatment Market Growth Rate Analysis
  • 5.4. Global Lichen Nitidus Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Lichen Nitidus Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Lichen Nitidus Treatment Total Addressable Market (TAM)

6. Lichen Nitidus Treatment Market Segmentation

  • 6.1. Global Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral
  • Topical
  • 6.2. Global Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Corticosteroids
  • Retinoid
  • Antihistamines
  • Phototherapy
  • 6.3. Global Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Dermatology Clinics
  • Other End Users
  • 6.4. Global Lichen Nitidus Treatment Market, Sub-Segmentation Of Oral, By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oral Medications (Steroids)
  • Oral Medications (Immunosuppressants)
  • Oral Antihistamines
  • Oral Retinoids
  • 6.5. Global Lichen Nitidus Treatment Market, Sub-Segmentation Of Topical, By Category, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Steroids
  • Topical Calcineurin Inhibitors
  • Topical Retinoids
  • Topical Antihistamines
  • Topical Phototherapy

7. Lichen Nitidus Treatment Market Regional And Country Analysis

  • 7.1. Global Lichen Nitidus Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Lichen Nitidus Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lichen Nitidus Treatment Market

  • 8.1. Asia-Pacific Lichen Nitidus Treatment Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lichen Nitidus Treatment Market

  • 9.1. China Lichen Nitidus Treatment Market Overview
  • 9.2. China Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lichen Nitidus Treatment Market

  • 10.1. India Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lichen Nitidus Treatment Market

  • 11.1. Japan Lichen Nitidus Treatment Market Overview
  • 11.2. Japan Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lichen Nitidus Treatment Market

  • 12.1. Australia Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lichen Nitidus Treatment Market

  • 13.1. Indonesia Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lichen Nitidus Treatment Market

  • 14.1. South Korea Lichen Nitidus Treatment Market Overview
  • 14.2. South Korea Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lichen Nitidus Treatment Market

  • 15.1. Western Europe Lichen Nitidus Treatment Market Overview
  • 15.2. Western Europe Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lichen Nitidus Treatment Market

  • 16.1. UK Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lichen Nitidus Treatment Market

  • 17.1. Germany Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lichen Nitidus Treatment Market

  • 18.1. France Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lichen Nitidus Treatment Market

  • 19.1. Italy Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lichen Nitidus Treatment Market

  • 20.1. Spain Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lichen Nitidus Treatment Market

  • 21.1. Eastern Europe Lichen Nitidus Treatment Market Overview
  • 21.2. Eastern Europe Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lichen Nitidus Treatment Market

  • 22.1. Russia Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lichen Nitidus Treatment Market

  • 23.1. North America Lichen Nitidus Treatment Market Overview
  • 23.2. North America Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lichen Nitidus Treatment Market

  • 24.1. USA Lichen Nitidus Treatment Market Overview
  • 24.2. USA Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lichen Nitidus Treatment Market

  • 25.1. Canada Lichen Nitidus Treatment Market Overview
  • 25.2. Canada Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lichen Nitidus Treatment Market

  • 26.1. South America Lichen Nitidus Treatment Market Overview
  • 26.2. South America Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lichen Nitidus Treatment Market

  • 27.1. Brazil Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lichen Nitidus Treatment Market

  • 28.1. Middle East Lichen Nitidus Treatment Market Overview
  • 28.2. Middle East Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lichen Nitidus Treatment Market

  • 29.1. Africa Lichen Nitidus Treatment Market Overview
  • 29.2. Africa Lichen Nitidus Treatment Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Lichen Nitidus Treatment Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Lichen Nitidus Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lichen Nitidus Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Lichen Nitidus Treatment Market Competitive Landscape
  • 30.2. Lichen Nitidus Treatment Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Lichen Nitidus Treatment Market Other Major And Innovative Companies

  • 31.1. Sanofi S.A.
  • 31.2. Bristol-Myers Squibb Co.
  • 31.3. AstraZeneca Plc
  • 31.4. GlaxoSmithKline Plc
  • 31.5. Roche Holding AG
  • 31.6. Takeda Pharmaceutical Company Limited
  • 31.7. Amgen Inc.
  • 31.8. Eli Lilly and Company
  • 31.9. Regeneron Pharmaceuticals Inc.
  • 31.10. Biogen Inc.
  • 31.11. UCB Pharma Ltd.
  • 31.12. Sun Pharmaceutical Industries Ltd.
  • 31.13. Incyte Corporation
  • 31.14. Kyowa Kirin Co. Ltd.
  • 31.15. Mallinckrodt Pharmaceuticals Plc

32. Global Lichen Nitidus Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lichen Nitidus Treatment Market

34. Recent Developments In The Lichen Nitidus Treatment Market

35. Lichen Nitidus Treatment Market High Potential Countries, Segments and Strategies

  • 35.1 Lichen Nitidus Treatment Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Lichen Nitidus Treatment Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Lichen Nitidus Treatment Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer
  • 250423_r33498_Lichen_Nitidus_Treatment_GMR_2025